Skip to main content

COVID-19-vaccine/nivolumab/pembrolizumab

Autoimmune encephalitis and confusion: case report

    Reactions Weekly volume 1936, page 176 (2022)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    USD 49.95

    Price excludes VAT (USA)
    Tax calculation will be finalised during checkout.

    Reference

    • Ser MH, et al. Recurrent autoimmune encephalitis related to immune checkpoint inhibitors. Epileptic Disorders 24: 609-613, No. 3, Jun 2022. Available from: URL: http://doi.org/10.1684/epd.2022.1425

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    COVID-19-vaccine/nivolumab/pembrolizumab. Reactions Weekly 1936, 176 (2022). https://doi.org/10.1007/s40278-022-29373-8

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40278-022-29373-8